学术探索
学术期刊
新闻热点
数据分析
智能评审

'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes

被引：3
作者：
Antman, EM [1 ]
机构：
[1] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷 / 18期
关键词：
D O I：
10.1053/euhj.2001.3270
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1408 / 1411
页数：4
相关论文
共 20 条
  • [1] Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction - TIMI 11B-ESSENCE meta-analysis
    Antman, EM
    Cohen, M
    Radley, D
    McCabe, C
    Rush, J
    Premmereur, J
    Braunwald, E
    [J]. CIRCULATION, 1999, 100 (15) : 1602 - 1608
  • [2] Troponin measurements in ischemic heart disease: More than just a black and white picture
    Antman, EM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) : 987 - 990
  • [3] Bazzino O, 1998, NEW ENGL J MED, V338, P1498
  • [4] Bazzino O, 1998, NEW ENGL J MED, V338, P1488
  • [5] Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes -: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention
    Boersma, E
    Akkerhuis, KM
    Théroux, P
    Califf, RM
    Topol, EJ
    Simoons, ML
    [J]. CIRCULATION, 1999, 100 (20) : 2045 - 2048
  • [6] Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials
    Boersma, E
    Harrington, RA
    Moliterno, DJ
    White, H
    Théroux, P
    Van de Werf, F
    de Torbal, A
    Armstrong, PW
    Wallentin, LC
    Wilcox, RG
    Simes, J
    Califf, RM
    Topol, EJ
    Simoons, ML
    [J]. LANCET, 2002, 359 (9302) : 189 - 198
  • [7] BRAUNWALD E, 2002, ACC AHA GUIDELINE UP
  • [8] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY
    CALIFF, RM
    SHADOFF, N
    VALETT, N
    BATES, E
    GALEANA, A
    KNOPF, W
    SHAFTEL, J
    BENDER, MJ
    AVERSANO, T
    RAQUENO, J
    GURBEL, P
    COWFER, J
    COHEN, M
    CROSS, P
    BITTL, J
    EDDINGS, K
    TAYLOR, M
    DEROSA, K
    HATTEL, L
    COOPER, L
    ESHELMAN, B
    FINTEL, D
    NIEMYSKI, P
    KLEIN, L
    KENNEDY, H
    THORNTON, T
    KEREIAKES, D
    MARTIN, L
    ANDERSON, L
    HIGBY, N
    ELLIS, S
    BREZINA, K
    GEORGE, B
    CHAPEKIS, A
    SMITH, D
    ANWAR, A
    GERBER, TL
    PRITCHARD, GL
    MYLER, R
    SHAW, R
    MURPHY, M
    WARD, K
    MADIGAN, NP
    BLANKENSHIP, J
    HALBERT, M
    FLANAGAN, C
    TANNENBAUM, M
    POLICH, M
    STEVENSON, C
    TCHENG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) : 956 - 961
  • [9] Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon, CP
    Weintraub, WS
    Demopoulos, LA
    Vicari, R
    Frey, MJ
    Lakkis, N
    Neumann, FJ
    Robertson, DH
    DeLucca, PT
    DiBattiste, PM
    Gibson, CM
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) : 1879 - 1887
  • [10] Hanrath P, 1997, CIRCULATION, V96, P1445
12